|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2001-7-3
|
|
pubmed:abstractText |
The Heart and Estrogen/progestin Replacement Study (HERS) was the first randomized clinical trial of combined hormone therapy and secondary prevention of coronary events. The trial had overall null results but reported an unexpected increased risk for recurrent events in the initial year, followed by a decrease during the final years.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0003-4819
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
3
|
|
pubmed:volume |
135
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1-8
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11434726-Adult,
pubmed-meshheading:11434726-Coronary Artery Disease,
pubmed-meshheading:11434726-Drug Administration Schedule,
pubmed-meshheading:11434726-Female,
pubmed-meshheading:11434726-Hormone Replacement Therapy,
pubmed-meshheading:11434726-Humans,
pubmed-meshheading:11434726-Logistic Models,
pubmed-meshheading:11434726-Middle Aged,
pubmed-meshheading:11434726-Myocardial Infarction,
pubmed-meshheading:11434726-Postmenopause,
pubmed-meshheading:11434726-Prospective Studies,
pubmed-meshheading:11434726-Questionnaires,
pubmed-meshheading:11434726-Recurrence,
pubmed-meshheading:11434726-Research Design,
pubmed-meshheading:11434726-Time Factors
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. a prospective, observational study.
|
|
pubmed:affiliation |
Channing Laboratory, 181 Longwood Avenue, Boston, MA 02115, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
